Top

Reactions Weekly

Published in:

01-03-2022 | Myalgie | Case report

Rosuvastatin

Liver injury, myalgia and rhabdomyolysis: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mercep I, et al. Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study. European Journal of Clinical Pharmacology 78: 227-236, No. 2, Feb 2022. Available from: URL: http://doi.org/10.1007/s00228-021-03233-7

Title: Rosuvastatin
Liver injury, myalgia and rhabdomyolysis: 2 case reports
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Myalgie
Myalgia
Rosuvastatin
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-12316-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Rosuvastatin

Liver injury, myalgia and rhabdomyolysis: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Daptomycin/gentamicin/vancomycin

Amlodipine/clonazepam/escitalopram

Regorafenib

Botulinum toxin-A

Flecainide

V-503